Press Release Archive

04.08.2013

Pfizer Launches Third Integrated Annual Review

04.03.2013

Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don’t Let Pain Hold Them Back

04.03.2013

BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins

04.03.2013

CHOP Collaborates With Pfizer’s Centers For Therapeutic Innovation To Speed Pediatric Research & Development

03.27.2013

Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission

03.26.2013

Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts

03.24.2013

Over 50? Of Course You’ve Still Got It, and the Y and Pfizer are Launching 50 MOVING FORWARD to Help You Keep It

03.24.2013

XELJANZ® (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA)

03.10.2013

New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.

03.04.2013

United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib capsules)

03.04.2013

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevnar 13® In Adults With HIV

02.20.2013

Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures